Stämm Biotech

Recent Finacing

Series A

Recent Raise

$17M

Stämm Biotech develops a desktop-sized, 3D-printed microfluidic bioreactor and software that designs dense nutrient/oxygen channel networks to culture cells without tanks, stirrers, or tubing for biomanufacturing.

Founded 2014

California, United States

11-50

Private

stamm.bio

Highlights

Focus Areas

Biotechnology

Information Technology

Life Science

Recent Investors

Financials

$17M

Total Raised

1

Funding round

13

Investors

Team

Upgrade to view the team

See the team members at Stämm Biotech.